Zobrazeno 1 - 10
of 22
pro vyhledávání: '"A.N. van Geel"'
Autor:
Cees Verhoef, Jan P. Deroose, Alexander M.M. Eggermont, A.N. van Geel, Dirk J. Grünhagen, J.H.W. de Wilt
Publikováno v:
British Journal of Surgery, 98, 1573-80
British Journal of Surgery, 98, 11, pp. 1573-80
British Journal of Surgery, 98(11), 1573-1580. John Wiley & Sons Ltd.
British Journal of Surgery, 98, 11, pp. 1573-80
British Journal of Surgery, 98(11), 1573-1580. John Wiley & Sons Ltd.
Background The use of tumour necrosis factor (TNF) α in isolated limb perfusion (ILP) for in-transit melanoma metastasis is not uniformly accepted. This article reports the long-term results of adding TNF-α to standard melphalan-based ILP (TM-ILP)
Autor:
J.G.M. Klijn, Marian B. E. Menke-Pluymers, Hanne Meijers-Heijboer, Curt W. Burger, C.C.M. Bartels, A.M.M. Eggermont, A.N. van Geel, M.M.A. Tilanus-Linthorst, Mieke Kriege, Caroline Seynaeve, A. vd Ouweland, C.T.M. Brekelmans
Publikováno v:
European Journal of Cancer, 43(5), 867-876. Elsevier Ltd.
European journal of cancer (Oxford, England, 43(5), 867-876. Elsevier Limited
European journal of cancer (Oxford, England, 43(5), 867-876. Elsevier Limited
Aim of the study Results on tumour characteristics and survival of hereditary breast cancer (BC), especially on BRCA2-associated BC, are inconclusive. The prognostic impact of the classical tumour and treatment factors in hereditary BC is insufficien
Ipsilateral breast tumour recurrence in hereditary breast cancer following breast-conserving therapy
Autor:
Caroline Seynaeve, E.J. Meijers-Heijboer, Anja Wagner, Carien L. Creutzberg, Martinus F. Niermeijer, C.T.M. Brekelmans, A.N. van Geel, A. M. W. Van Den Ouweland, L.M.C van de Bosch, L.C. Verhoog, J.G.M. Klijn, Marian B. E. Menke-Pluymers
Publikováno v:
European Journal of Cancer, 40, 1150-1158. Elsevier Ltd.
European journal of cancer (Oxford, England, 40(8), 1150-1158. Elsevier Limited
European Journal of Cancer, 40, 8, pp. 1150-8
European Journal of Cancer, 40, 1150-8
European journal of cancer (Oxford, England, 40(8), 1150-1158. Elsevier Limited
European Journal of Cancer, 40, 8, pp. 1150-8
European Journal of Cancer, 40, 1150-8
Contains fulltext : 57795.pdf (Publisher’s version ) (Closed access) The overall rate of an ipsilateral breast tumour recurrence (IBTR) after breast-conserving therapy (BCT) ranges from 1% to 2% per year. Risk factors include young age but data on
Autor:
Emiel J. Th. Rutgers, J Berner, Catherine Legrand, Marie-Rose Christiaens, Robert Paridaens, G de Keizer, J. Wildiers, Patrick Therasse, A.N. van Geel, M Nagadowska, Ian S. Fentiman
Publikováno v:
European Journal of Cancer. 39:309-316
For treatment of early breast cancer in older women, little evidence is available from randomised trials. We conducted a randomised trial comparing modified radical mastectomy (MRM) with tamoxifen (TAM) as the sole initial therapy in 164 patients age
Autor:
J.G.M. Klijn, Caroline Seynaeve, Peter Devilee, A.N. van Geel, L. Dukel, C.T.M. Brekelmans, L.C. Verhoog, Amw van den Ouweland, Mma Tilanus-Linthorst, E.J. Meijers-Heijboer, Anja Wagner
Publikováno v:
Lancet, 355(9220), 2015-2020. Elsevier Limited
Lancet (UK), 355, 2015-2020. Elsevier Ltd.
Lancet (UK), 355, 2015-2020. Elsevier Ltd.
Germline mutations in the BRCA1 and BRCA2 genes highly predispose to breast and ovarian cancer. In families with BRCA1 or BRCA2 mutations, identification of mutation carriers is clinically relevant in view of the options for surveillance and preventi
Autor:
M.M.A. Tilanus-Linthorst, L.C. Verhoog, E.J. Meijers-Heijboer, Anja Wagner, A.N. van Geel, Peter Devilee, C.C.M. Bartels, D. J. J. Halley, J.G.M. Klijn, A. M. W. Van Den Ouweland, Caroline Seynaeve, C.T.M. Brekelmans, G. Dahmen
Publikováno v:
Journal of clinical oncology, 17(11), 3396-3402. American Society of Clinical Oncology
PURPOSE: Breast cancer in BRCA1 and BRCA2 gene-mutation carriers may differ from so-called sporadic breast cancer in clinical features and behavior. These potential differences may be of importance for the prevention, screening, and, ultimately, trea
Autor:
G. Botke, J.W.W. Coebergh, E.J.Th. Rutgers, Adri C. Voogd, A.N. van Geel, C.T.M. Brekelmans, J.G.M. Klijn, P. Rodrigus
Publikováno v:
European Journal of Cancer, 35(4), 620-626. Elsevier Ltd.
The impact of a family history of breast cancer on the local recurrence (LR) risk after breast-conserving therapy (BCT) was performed within the framework of a large, multicentre matched case–control study of risk factors for LR after BCT (BORST st
Autor:
Caroline Seynaeve, A. M. W. Van Den Ouweland, G. Dahmen, Mma Tilanus-Linthorst, C.T.M. Brekelmans, A.N. van Geel, E.J. Meijers-Heijboer, Anja Wagner, Lmc van den Bosch, J.G.M. Klijn, Peter Devilee, Ccm Bartels, L.C. Verhoog
Publikováno v:
Lancet, 351(9099), 316-321. Elsevier Limited
Lancet (UK), 351, 316-321. Elsevier Ltd.
Lancet (UK), 351, 316-321. Elsevier Ltd.
Hereditary breast cancer has been associated with mutations in the BRCA1 and BRCA2 genes and has a natural history different from sporadic breast cancer. We investigated disease-free and overall survival for patients with a proven BRCA1 alteration. W
Autor:
Hugo J. Duivenvoorden, Caroline Seynaeve, M. Menke, A. R. Van Gool, Aad Tibben, Martinus F. Niermeijer, Paula J.C. Bresser, J.G.M. Klijn, A.N. van Geel
Publikováno v:
Annals of Oncology, 18, 10, pp. 1641-5
Annals of Oncology, 18, 1641-5
Annals of Oncology, 18(10), 1641-1645. Elsevier Ltd.
Annals of Oncology, 18, 1641-5
Annals of Oncology, 18(10), 1641-1645. Elsevier Ltd.
Contains fulltext : 52057.pdf (Publisher’s version ) (Closed access) BACKGROUND: The present study aimed to assess predictors of distress after 'prophylactic mastectomy (PM) and salpingo-ovariectomy (PSO), in order to enable the early identificatio
Publikováno v:
European Journal of Surgical Oncology, 32(4), 371-380. W.B. Saunders
AIMS: The treatment of melanoma in-transit metastases (IT-mets) can vary widely and is dependant on the size and the number of the lesions. When multiple, large lesions exist, isolated limb perfusion (ILP) has established itself as an attractive trea